Latest news
Health Canada review path for PrimeC: NeuroSense (NASDAQ: NRSN) - Stock TitanStock Titan · Thu, 06 Aug 2026 15:56:23 GMTNeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada - PR NewswirePR Newswire · Thu, 06 Aug 2026 15:29:00 GMTNeuroSense Therapeutics Ltd. SEC Filing (Aug 3, 2026) - Stock TitanStock Titan · Mon, 03 Aug 2026 10:13:46 GMTNeuroSense Therapeutics (NRSN) seeks reverse split amid Nasdaq compliance push - Stock TitanStock Titan · Fri, 31 Jul 2026 20:16:46 GMTNeuroSense Therapeutics (NRSN) revises Capital on Demand share sales deal - Stock TitanStock Titan · Fri, 31 Jul 2026 07:00:00 GMT